<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Effect of ipratropium bromide versus metaproterenol in patients with COPD without asthma or atopy</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Effect of ipratropium bromide versus metaproterenol in patients with COPD without asthma or atopy</h1>
<div class="graphic"><div class="figure"><div class="ttl">Effect of ipratropium bromide versus metaproterenol in patients with COPD without asthma or atopy</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Mean percentage changes in FEV<sub>1</sub> at serial times after inhalation of ipratropium bromide (40 mcg) or metaproterenol (1500 mcg) on day 90 of the 90 day trial period of daily drug administration. Ipratropium was more potent at the peak of its effect and was longer acting than the adrenergic agent. Similar results were demonstrated on days 1 and 45 (not shown).</div><div class="graphic_footnotes">FEV<sub>1</sub>: forced expiratory volume in one second.<br/>* p≤0.05.<br/><font class="bullet">•</font> p≤0.01.</div><div class="graphic_reference">Redrawn from: Tashkin DP, Ashutosh K, Bleecker ER, et al. Am J Med 1986; 81(Suppl A):81.</div><div id="graphicVersion">Graphic 73667 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
